Articles

Browse our regulatory articles below or search through our archive.

 


 

Kickstart a Medtech Start-Up Initiative

by Arazy Group | Sep 29, 2017

It is not easy to bring a start-up company to success. It is even more challenging for Medtech Start-ups due to the heavily regulated nature of medical devices. For the past 22 years, we have been fortunate to witness incredible inventions and technology developed into medical and IVD devices by thousands of young companies all around the world. However, relatively few of these great products can be found in global markets today. Why is that?

The reasons are diverse, but mostly they amount to the inability of a start-up company to reach a "critical mass". In the Medtech space that "critical mass" equates to having an approved product for sale in the US and/or the EU markets as well as a quality, reliable medical device manufacturer behind it. 

Consequently, Arazy Group is kick-starting a "Medtech Start-up initiative" that will allow more young companies to reach that "critical mass". The objective of this initiative is to significantly increase the availability of advanced solutions and medical device technology to physicians and their patients around the world. If you are a start-up company, three to twenty-four months old and managing a budget of less than $500,000 US annually, please complete our application form to see if your company is eligible for any (or all) of the following products, sponsored by LICENSALE.COM:

I) A Regulatory Strategic Report for your product’s US and EU pre market clearance. (Class I/II/III)
II) An Established ISO13485/21 CFR 820 Quality Management System.
III) Your product’s CE Mark:
     1) EU - Class I/II Technical File
     2) EU - Authorized Representative service
IV) Your product’s US - FDA clearance for a Class I/II product
     3) USA - Medical Device Registration | 510(k)
     4) The USA - Regulatory Designated Agent

Arazy Group Consultant Inc. has been a leading Medtech regulatory affairs firm since 1995. Operating in hundreds of countries, assisting manufacturers to obtain their product approvals for market access and their companies certified for quality marks. LICENSALE.COM, Arazy Group’s awarded propriety technology, is the only MedTech registration solution that brings any medical device to any market around the world faster and more efficiently than current alternative practices, generating revenues months in advance.  For more information about the Medtech Start-Up initiative and the qualification requirements, please complete this ONLINE FORM.  

 

Category:
  • Blog
Tags:
  • Initiative
  • Start-Up
  • medtech
latest news
  • Apr 9 2018
    MDSAP Transition in Canada

    Health Canada is allowing a "grandfather" period in 2019 for applicants who do not have an MDSAP certificate issued by December 31, 2018....

    Read More
  • Apr 9 2018
    REGULATORY UPDATE - ALPHA BIO

    Italy: Alpha Bios' GSTK (Implant Mount CS) was approved for sale with LICENSALE.COM®....

    Read More
  • Mar 26 2018
    REGULATORY UPDATE - DR. KORMAN LABORATORIES

    Peru: Dr. Korman Laboratories' Dermal Fillers were approved for sale with LICENSALE.COM®....

    Read More
  • Mar 22 2018
    REGULATORY UPDATE - CLARIUS MOBILE HEALTH

    Ecuador: Clarius Mobile Health's Clarius Ultrasound Scanner was approved for sale with LICENSALE.COM®....

    Read More
  • Mar 22 2018
    REGULATORY UPDATE - SPD

    Peru: SPD's CB 9 and CB11 were approved for sale with LICENSALE.COM®....

    Read More

VANCOUVER OFFICE

  • Phone +1 604.681.6888
  • Fax +1 604.681.6822
  • info@arazygroup.com
  •  
  • #350-1333 Johnston Street
  • Pier 32, Granville Island
  • Vancouver, British Columbia
  • Canada V6H 3R9

BACK TO TOP